NDC 33261-019-10 - CELEBREX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 33261-019
- Requested NDC
- 33261-019-10
- Package NDCs from labels
- 33261-019-10, 33261-019-34, 33261-019-30, 33261-019-60
- Manufacturer
- Aidarex Pharmaceuticals LLC
- Effective date
- 2012-09-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CELEBREX - Aidarex Pharmaceuticals LLC | Aidarex Pharmaceuticals LLC | 2012-09-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 33261-019-10 | CELEBREX | 10 in 1 BOTTLE, PLASTIC | CAPSULE | 10 | 1 | |
| 33261-019-30 | CELEBREX | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 1 | |
| 33261-019-34 | CELEBREX | 10 in 1 CARTON | CAPSULE | 10 | 1 | |
| 33261-019-60 | CELEBREX | 60 in 1 BOTTLE, PLASTIC | CAPSULE | 60 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 33261-019-10 | EA - Each | 33261-019 | 2d59dde0-26e3-486c-a6e0-14d42fb4bc5b | 1 | 2015-10-02 |
| 33261-019-30 | EA - Each | 33261-019 | 37d175b5-dd8d-4196-95f9-512e3419bf00 | 1 | 2015-10-02 |
| 33261-019-60 | EA - Each | 33261-019 | 8e8ccf32-0c3c-45df-b10f-4f9ef51c35ab | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CELECOXIB | ACTIVE INGREDIENT | JCX84Q7J1L | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| CELECOXIB | ACTIVE MOIETY | JCX84Q7J1L | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CELEBREX (CELECOXIB) CAPSULE [AIDAREX PHARMACEUTICALS LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Celecoxib | CELECOXIB | Proficient Rx LP | c529b321-38ed-434f-b76e-06902cdd40dc | 2023-12-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| celecoxib | CELECOXIB | Asclemed USA, Inc. | 2a926010-08e1-44dd-bc6d-ed15374bd0d3 | 2023-09-02 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | A-S Medication Solutions | 00e67d5e-df6f-4dfd-8c2d-a001c8a99af0 | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | BioActive Nutritional | 3382df85-3ec5-4371-830e-4ed345b8f51b | 2023-07-14 | Warnings | 368GB5141J |
| Pneumotox | TRITICUM AESTIVUM, ALFALFA, ARNICA MONTANA, ASCLEPIAS TUBEROSA, CHAMOMILLA, ECHINACEA (ANGUSTIFOLIA), EUCALYPTUS GLOBULUS, FUCUS VESICULOSUS, HORDEUM VULGARE, IODIUM, NASTURTIUM AQUATICUM, PLANTAGO MAJOR, RAPHANUS SATIVUS, TRIFOLIUM PRATENSE, TRIGONELLA FOENUM-GRAECUM, SYMPHYTUM OFFICINALE, LUNG (SUIS), ORYZA SATIVA, SILICEA, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, NATRUM MURIATICUM, NITRICUM ACIDUM, | BioActive Nutritional, Inc. | f8846fb1-92e5-4f8e-b3b3-bc620df90a62 | 2023-07-12 | Warnings | 368GB5141J |
| Celecoxib | CELECOXIB | Proficient Rx LP | b9a7f32c-8136-4f29-be6b-4d5e904ca0f1 | 2023-05-01 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | A-S Medication Solutions | c7a183dc-f4d5-483f-964c-f2745a3640ad | 2023-02-28 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| celecoxib | CELECOXIB | A-S Medication Solutions | 85bfe02b-bfcb-44ee-81a0-11765c3054a9 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Petrochemical Detox | CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SYMPHYTUM OFFICINALE, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, CADMIUM SULPHURATUM, GELSEMIUM SEMPERVIRENS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PLATINUM METALLICUM, LATRODECTUS MACTANS | Deseret Biologicals, Inc. | b38b492a-cf45-4aa2-ba7e-4573d2c4ebe5 | 2023-01-12 | Warnings | 368GB5141J |
| celecoxib | CELECOXIB | Proficient Rx LP | 0ad14a4e-2f05-4ce7-93d1-1cb7e4d8f7d0 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| celecoxib | CELECOXIB | Proficient Rx LP | cbd2d6de-6f0d-4b69-8e27-a1fe08830ba5 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Tianjin Tianyao Pharmaceuticals Co., Ltd. | 76f9bcb7-0e94-485f-816d-61d4e1ed24e0 | 2022-02-28 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Aphena Pharma Solutions - Tennessee, LLC | d258e065-e9a6-44e2-89c9-6892d771d9d3 | 2021-08-09 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Proficient Rx LP | c91e5933-1798-4096-9f08-fb1200e154e1 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Proficient Rx LP | 6dd743d3-4821-4919-90eb-6d306ca7999f | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib 200 mg | CELECOXIB | Proficient Rx LP | feee6a01-63f9-42c3-8bd8-ca713a08b36d | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Proficient Rx LP | 7a234c0c-30a7-49f5-92a1-a1fc836ff9ae | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Proficient Rx LP | c787b0ab-77ab-4f7e-9fea-be2a0085020a | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| bcb89362-3e1a-41ed-ba17-d740662897e0 | 814511c9-89ef-42d7-912e-c00147833b7e | 2012-09-12 | Boxed warning, Warnings, Adverse reactions | bcb89362-3e1a-41ed-ba17-d740662897e0 814511c9-89ef-42d7-912e-c00147833b7e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.